PARP Inhibitors Could Enhance Immunotherapy Response in Mesothelioma
A new study suggests that drugs known as PARP inhibitors may enhance immunotherapy response in mesothelioma patients. According to a…
Get the latest details on current events, medical progress, and therapies used by mesothelioma patients around the globe. Learn More.